In cases of pathogenic variants in the MAPT gene, the most frequently described clinical syndromes are bvFTD (44%), progressive supranuclear palsy (4%), and Parkinson’s disease (5%).71 This evidence concerns the gene MAPT and progressive supranuclear palsy.